You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 17, May 7, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Birth Defects and Vaginal Spermicides

Samuel Shapiro, MB, FRCP(E); Dennis Slone, MD; Olli P. Heinonen, MD, DSc; David W. Kaufman, MS; Lynn Rosenberg, ScD; Allen A. Mitchell, MD; Susan P. Helmrich, MS

JAMA. 1982;247(17):2381-2384.


Abstract

In a cohort study of 50,282 pregnancies recruited between 1958 and 1965, there were 462 gravidae who used nonmercurial spermicides (mostly nonoxynol-9 and octoxynol); the estimated rate ratio for major malformations was 0.9 (95% confidence limits, 0.6 to 1.6). There were also 889 women who used phenylmercuric acetate (no longer available as a spermicide); the corresponding rate ratio was 0.9 (0.6 to 1.3). Limb reduction deformities, neoplasms, Down's syndrome, and hypospadias did not occur in excess in children exposed to spermicides.

(JAMA 1982;247:2381-2384)



Author Affiliations

From the Drug Epidemiology Unit, School of Public Health, Boston University School of Medicine, Cambridge, Mass (Drs Shapiro, Slone, Rosenberg, and Mitchell, Mr Kaufman, and Ms Helmrich), the Department of Epidemiology. University of Kuopio, Kuopio, Finland (Dr Heinonen), and the Department of Pediatrics, Clinical Pharmacology Unit, Harvard Medical School, Boston (Dr Mitchell).


Footnotes

Reprint requests to Drug Epidemiology Unit, Boston University Medical Center, 777 Concord Ave, Cambridge, MA 02138 (Dr Shapiro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Final Report on the Safety Assessment of Octoxynol-1, Octoxynol-3, Octoxynol-5, Octoxynol-6, Octoxynol-7, Octoxynol-8, Octoxynol-9, Octoxynol-10, Octoxynol-11, Octoxynol-12, Octoxynol-13, Octoxynol-16, Octoxynol-20, Octoxynol-25, Octoxynol-30, Octoxynol-33, Octoxynol-40, Octoxynol-70, Octoxynol-9 Carboxylic Acid, Octoxynol-20 Carboxylic Acid, Potassium Octoxynol-12 Phosphate, Sodium Octoxynol-2 Ethane Sulfonate, Sodium Octoxynol-2 Sulfate, Sodium Octoxynol-6 Sulfate, and Sodium Octoxynol-9 Sulfate
International Journal of Toxicology 2004;23:59-111.
ABSTRACT | FULL TEXT  

Condom Use by Adolescents
Committee on Adolescence
Pediatrics 2001;107:1463-1469.
ABSTRACT | FULL TEXT  

State-by-State Pharmaceutical Formulations?
Frankel and Furey
NEJM 1993;328:1500-1501.
FULL TEXT  

Reporting Provocative Results: Can We Publish 'Hot' Papers Without Getting Burned?
Mills
JAMA 1987;258:3428-3429.
ABSTRACT  

Male contraception -- a review
Donaldson
The Journal of the Royal Society for the Promotion of Health 1985;105:91-98.
 

Are Spermicides Teratogenic?
Mills et al.
JAMA 1982;248:2148-2151.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.